Loading...
Loading...
India's tacrolimus imports from UNITED STATES total $447.7K across 133 shipments from 15 foreign suppliers. NEW LIFE MEDICALS (USA) INC. leads with $125.5K in import value; the top 5 suppliers together control 63.6% of this origin. Leading Indian buyers include ZYDUS LIFESCIENCES LIMITED. This corridor reflects India's pharmaceutical import demand for tacrolimus — a diversified sourcing base with multiple active suppliers from UNITED STATES.

NEW LIFE MEDICALS (USA) INC. is the leading Tacrolimus supplier from UNITED STATES to India, with import value of $125.5K across 2 shipments. The top 5 suppliers — NEW LIFE MEDICALS (USA) INC., NEWLIFE MEDICALS (USA). INC., AGRACE PHARMA, NEW LIFE MEDICALS (USA).INC., ASCENT PHARMACEUTICALS INC. — collectively account for 63.6% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEW LIFE MEDICALS (USA) INC. | $125.5K | 2 | 28.0% |
| 2 | NEWLIFE MEDICALS (USA). INC. | $57.0K | 18 | 12.7% |
| 3 | AGRACE PHARMA | $40.4K | 13 | 9.0% |
| 4 | NEW LIFE MEDICALS (USA).INC. | $35.0K | 2 | 7.8% |
| 5 | ASCENT PHARMACEUTICALS INC. | $26.8K | 9 | 6.0% |
| 6 | INWOOD PHARMA INC | $23.9K | 3 | 5.3% |
| 7 | ACCORD FARMACEUTCA LTDA | $14.6K | 2 | 3.3% |
| 8 | GREENE-VAN PHARMACY CORP | $12.4K | 4 | 2.8% |
| 9 | RUBIN CHEMISTS | $11.8K | 9 | 2.6% |
| 10 | M/S. BM CLINICAL BV | $10.4K | 3 | 2.3% |
| 11 | ROCHE DIAGNOSTICS INTERNATIONAL LTD | $8.8K | 1 | 2.0% |
| 12 | AGRACE PHARMA. | $8.5K | 4 | 1.9% |
| 13 | ESPEE BIOPHARMA & FINECHEM LLC | $7.3K | 3 | 1.6% |
| 14 | NATIONWIDE MEDICAL SURGICAL | $6.6K | 2 | 1.5% |
| 15 | SUN PHARMACEUTICAL INDUSTRIES INC. | $6.5K | 4 | 1.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | $130.2K | 8 | 29.1% |
| 2 | AUROBINDO PHARMA LTD | $60.8K | 30 | 13.6% |
| 3 | INTAS PHARMACEUTICALS LIMITED | $50.6K | 8 | 11.3% |
| 4 | RUBICON RESEARCH PRIVATE LIMITED | $39.1K | 5 | 8.7% |
| 5 | GLENMARK PHARMACEUTICALS LIMITED | $26.5K | 6 | 5.9% |
| 6 | DR.REDDY'S LABORATORIES LTD | $22.5K | 11 | 5.0% |
| 7 | CLIANS LABS PRIVATE LIMITED | $22.5K | 7 | 5.0% |
| 8 | ENCUBE ETHICALS PRIVATE LIMITED | $16.7K | 8 | 3.7% |
| 9 | CLIANTHA RESEARCH LIMITED | $13.6K | 4 | 3.0% |
| 10 | NOVARTIS HEALTHCARE PRIVATE LIMITED | $10.4K | 3 | 2.3% |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $9.8K | 7 | 2.2% |
| 12 | ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED | $8.8K | 1 | 2.0% |
| 13 | ALKEM LABORATORIES LIMITED | $7.9K | 4 | 1.8% |
| 14 | AUROBINDO PHARMA LIMITED | $6.4K | 8 | 1.4% |
| 15 | CONCORD BIOTECH LIMITED | $4.8K | 1 | 1.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tacrolimus suppliers from UNITED STATES to India include NEW LIFE MEDICALS (USA) INC., NEWLIFE MEDICALS (USA). INC., AGRACE PHARMA. The leading supplier is NEW LIFE MEDICALS (USA) INC. with import value of $125.5K USD across 2 shipments. India imported Tacrolimus worth $447.7K USD from UNITED STATES in total across 133 shipments.
India imported Tacrolimus worth $447.7K USD from UNITED STATES across 133 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tacrolimus sourced from UNITED STATES include ZYDUS LIFESCIENCES LIMITED, AUROBINDO PHARMA LTD, INTAS PHARMACEUTICALS LIMITED. The largest buyer is ZYDUS LIFESCIENCES LIMITED with $130.2K in imports across 8 shipments.
The total value of Tacrolimus imports from UNITED STATES to India is $447.7K USD, across 133 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
133 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists